High rates of psychiatric comorbidity in narcolepsy: Findings from the Burden of Narcolepsy Disease (BOND) study of 9,312 patients in the United States

Journal of Clinical Psychiatry

Volumn 78, Issue 2, 2017, Pages 171-176

  Ruoff, Chad M ^a   Reaven, Nancy L ^b   Funk, Susan E ^b   McGaughey, Karen J ^c   Ohayon, Maurice M ^a   Guilleminault, Christian ^e   Black, Jed ^d,e,f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Strategic Health Resources   (United States)

^c CALIFORNIA POLYTECHNIC STATE UNIVERSITY   (United States)

^d STANFORD UNIVERSITY   (United States)

^e STANFORD UNIVERSITY   (United States)

^f JAZZ PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANXIETY DISORDER; BIPOLAR DISORDER; COHORT ANALYSIS; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; ICD-9; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NARCOLEPSY; POPULATION RESEARCH; PREVALENCE; RETROSPECTIVE STUDY; UNITED STATES; YOUNG ADULT; ADOLESCENT; CATAPLEXY; COST OF ILLNESS; CROSS-SECTIONAL STUDY; HEALTH SURVEY; MENTAL DISORDERS; PSYCHOLOGY;

ADOLESCENT; ADULT; AGED; CATAPLEXY; COHORT STUDIES; COMORBIDITY; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NARCOLEPSY; UNITED STATES; YOUNG ADULT;

EID: 85014471525     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m10262     Document Type: Conference Paper

References (53)

1. Jennum P, Ibsen R, Petersen ER, et al. Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners. Sleep Med. 2012;13(8):1086-1093. doi:10.1016/j.slep. 2012.06.06
2. Panossian LA, Avidan AY. Narcolepsy and Other Comorbid Medical Illnesses. In: Goswami M, Thorpy MJ, Pandi-Perumal SR, eds. Narcolepsy: A Clinical Guide. Basel, Switzerland: Humana Press; 2008. doi:10.107/978-1-419-0854-410
3. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2. Rochester, MN: American Academy of Sleep Medicine; 2005.
4. Ohayon MM, Priest RG, Zulley J, et al. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology. 2002;58(12):1826-1833. doi:10.1212/WNL.58.12.1826
5. Morgenthaler TI, Kapur VK, Brown T, et al; Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2007;30(12):1705-1711.
6. Ohayon MM, Ferini-Strambi L, Plazzi G, et al. Frequency of narcolepsy symptoms and other sleep disorders in narcoleptic patients and their first-degree relatives. J Sleep Res. 2005;14(4):437-445. doi:10.1/j.1365-2869.205.0476.x
7. Daniels E, King MA, Smith IE, et al. Healthrelated quality of life in narcolepsy. J Sleep Res. 2001;10(1):75-81. doi:10.1046/j.1365-2869.201.0234.x
8. Morrish E, King MA, Smith IE, et al. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med. 2004;5(1):37-41. doi:10.1016/j.slep. 203.06.02
9. Luca G, Haba-Rubio J, Dauvilliers Y, et al; European Narcolepsy Network. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res. 2013;22(5):482-495. doi:10.1/jsr.1204
10. Kryger MH, Walid R, Manfreda J. Diagnoses received by narcolepsy patients in the year prior to diagnosis by a sleep specialist. Sleep. 2002;25(1):36-41.
11. Broughton R, Ghanem Q, Hishikawa Y, et al. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci. 1981;8(4):299-304. doi:10.1017/S03171671043419
12. Dodel R, Peter H, Walbert T, et al. The socioeconomic impact of narcolepsy. Sleep. 2004;27(6):1123-1128.
13. Godbout R, Montplaisir J. All-day performance variations in normal and narcoleptic subjects. Sleep. 1986;9(1 pt 2):200-204.
14. Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology. 1998;50(suppl 1):S31-S36. doi:10.1212/WNL.50.2Supl1. S31
15. Douglass AB. Narcolepsy: differential diagnosis or etiology in some cases of bipolar disorder and schizophrenia? CNS Spectr. 2003;8(2):120-126. doi:10.1017/S1092852901834
16. Bhat SK, Galang R. Narcolepsy presenting as schizophrenia. Am J Psychiatry. 2002;159(7):1245. doi:10.176/api.ajp. 159.7.1245
17. Kishi Y, Konishi S, Koizumi S, et al. Schizophrenia and narcolepsy: a review with a case report. Psychiatry Clin Neurosci. 2004;58(2):117-124. doi:10.1/j.140-1819.203.01204.x
18. Takeuchi N, Mukai M, Uchimura N, et al. A narcoleptic patient exhibiting hallucinations and delusion. Psychiatry Clin Neurosci. 2000;54(3):321-322. doi:10.1046/j.140-1819.20.0696.x
19. Melamed Y, Daliahu Y, Paleacu D. Narcolepsy and psychotic states-a case report. Isr J Psychiatry Relat Sci. 2009;46(1):70-73.
20. HCUP Clinical Classifications Software (CCS) for ICD-9-CM. Healthcare Cost and Utilization Project (HCUP) Web site. www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed September 26, 2011.
21. Black J, Reaven NL, Funk SE, et al. The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings. Sleep Med. 2014;15(5):522-529. doi:10.1016/j.slep. 2014.02.01
22. Ohayon MM. A longitudinal study of 322 individuals with narcolepsy. (abstract) Ann Neurol. 2012;72(suppl S16):52.
23. Ohayon MM, Black J, Lai C, et al. Increased mortality in narcolepsy. Sleep. 2014;37(3):439-444.
24. Goldstein TR, Bridge JA, Brent DA. Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol. 2008;76(1):84-91. doi:10.1037/02-06X.76.1.84
25. Kodaka M, Matsumoto T, Katsumata Y, et al. Suicide risk among individuals with sleep disturbances in Japan: a case-control psychological autopsy study. Sleep Med. 2014;15(4):430-435. doi:10.1016/j.slep. 2013.1.789
26. Pigeon WR, Pinquart M, Conner K. Metaanalysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry. 2012;73(9):e1160-e1167. doi:10.4088/JCP.11r07586
27. Singareddy R, Krishnamurthy VB, Vgontzas AN, et al. Subjective and objective sleep and selfharm behaviors in young children: a general population study. Psychiatry Res. 2013;209(3):549-553. doi:10.1016/j.psychres.2013.03.036
28. Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547. doi:10.1371/journal.pmed.101547
29. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. doi:10.101/archpsyc.62.6.593
30. Pedersen CB, Mors O, Bertelsen A, et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry. 2014;71(5):573-581. doi:10.101/jamapsychiatry.2014.16
31. Douglass AB, Hays P, Pazderka F, et al. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. J Nerv Ment Dis. 1991;179(1):12-18. doi:10.1097/05053-191010-03
32. Talih FR. Narcolepsy presenting as schizophrenia: a literature review and two case reports. Innov Clin Neurosci. 2011;8(4):30-34.
33. Canellas F, Lin L, Julià MR, et al. Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders. J Clin Sleep Med. 2014;10(9):1011-1018.
34. Vourdas A, Shneerson JM, Gregory CA, et al. Narcolepsy and psychopathology: is there an association? Sleep Med. 2002;3(4):353-360. doi:10.1016/S1389-9457 (02) 062-X
35. Fortuyn HA, Lappenschaar GA, Nienhuis FJ, et al. Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatry. 2009;31(2):146-154. doi:10.1016/j.genhospsych.208.12.02
36. Dahmen N, Kasten M, Mittag K, et al. Narcoleptic and schizophrenic hallucinations: implications for differential diagnosis and pathophysiology. Eur J Health Econ. 2002;3(suppl 2):S94-S98. doi:10.107/s10198-02-013-x
37. Huang YS, Guilleminault C, Chen CH, et al. Narcolepsy-cataplexy and schizophrenia in adolescents. Sleep Med. 2014;15(1):15-22. doi:10.1016/j.slep. 2013.09.018
38. Wilcox J. Psychopathology and narcolepsy. Neuropsychobiology. 1985;14(4):170-172. doi:10.159/01823
39. Douglass AB, Shipley JE, Haines RF, et al. Schizophrenia, narcolepsy, and HLA-DR15, DQ6. Biol Psychiatry. 1993;34(11):773-780. doi:10.1016/06-323 (93) 906-M
40. Cadieux RJ, Kales JD, Kales A, et al. Pharmacologic and psychotherapeutic issues in coexistent paranoid schizophrenia and narcolepsy: case report. J Clin Psychiatry. 1985;46(5):191-193.
41. Auger RR, Goodman SH, Silber MH, et al. Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a casecontrol study. Sleep. 2005;28(6):667-672.
42. Steiner J, Schiltz K, Bernstein HG, et al. Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications. CNS Drugs. 2015;29(3):197-206. doi:10.107/s40263-015-023-3
43. Debnath M, Cannon DM, Venkatasubramanian G. Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications. Prog Neuropsychopharmacol Biol Psychiatry. 2013;42:49-62. doi:10.1016/j.pnpbp. 2012.07.09
44. Mignot E, Lin L, Rogers W, et al. Complex HLADR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 2001;68(3):686-699. doi:10.1086/31879
45. Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol. 2013;23(5):767-773. doi:10.1016/j.conb.2013.04.013
46. Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med. 2013;14(6):488-492. doi:10.1016/j.slep. 2013.03.02
47. Jennum P, Ibsen R, Knudsen S, et al. Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study. Sleep. 2013;36(6):835-840.
48. Mayer G, Kesper K, Peter H, et al. Comorbidity in narcoleptic patients [in German]. Dtsch Med Wochenschr. 2002;127(38):1942-1946. doi:10.105/s-202-34207
49. Szucs A, Janszky J, Holló A, et al. Misleading hallucinations in unrecognized narcolepsy. Acta Psychiatr Scand. 2003;108(4):314-316, 316-317. doi:10.1034/j.160-047.203.014.x
50. Kaplan A. Comorbid Sleep and Psychiatric Disorders: Rx of the Former Can Improve the Latter. Psychiatric Times.com Web site. http://www.psychiatrictimes.com/apa2012/comorbid-sleep-and-psychiatric-disorders-rxformercan-improve-latter. Updated May 8, 2012. Accessed June 12, 2015.
51. Billiard M, Dauvilliers Y, Dolenc-Groselj L, et al. Management of narcolepsy in adults. In: Barnes MR, Brainin M, eds. European Handbook of Neurological Management. Vol. 1. 2nd ed. Gilhus, NE: Blackwell Publishing; 2011:513-528.
52. Mignot EJM. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics. 2012;9(4):739-752. doi:10.107/s131-012-0150-9
53. Ristanovic RK, Liang H, Hornfeldt CS, et al. Exacerbation of cataplexy following gradual withdrawal of antidepressants: manifestation of probable protracted rebound cataplexy. Sleep Med. 2009;10(4):416-421. doi:10.1016/j.slep. 208.04.04